Follow-The-Filings

COLL · Collegium Pharmaceutical Inc.

Q3 2022 13F holders

← latest ownership dossier

Ticker
COLL
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares